The suggestion of an increased risk of the borderline serous subtype of ovarian cancer among women with PCOS supports the hypothesis that androgens could be a factor in ovarian cancer development as androgen receptors have been shown to be higher in serous borderline tumors compared to serous invasive [52]. The gene discussed is AR; the disease is ovarian cancer.